In Alzheimer’s disease, Cerebro-Spinal Fluid (CSF) biomarkers such as Aβ42, phosphorylated tau (p-tau), and total tau (t-tau) are well-studied. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.